Tag Archive for: financing

Amplys team around CEO Ben Thomas (4th from left). © Amply Discovery Ltd

Belfast-based techbio company AMPLY Discovery Ltd announced today will make use of a £1.4m in grant funding to advance its AI-based drug discovery platform.

HBx biofarm in pilot scale. © HutanBio

British-Malasian marine algae biofuel start-up HutanBio has secured an £2.25m seed investment to produce carbon negative biodiesel in brackish water.

Heura co-founders Marc Coloma (left) and Bernat Ananos Martinez (right). © Heura

Spanish Food tech Start-up Heüra Foods secures €40m in Series B financing round to expand product distribution.

© magicmine - stock.adobe.com

Enterprise Therapeutics Ltd. has raised £26m for the Phase IIa trial of ETD001, a novel cystic fibrosis treatment, with investment led by Panakes Partners and participation from existing investors.

© Calluna Pharma, edited by BIOCOM

Forbion has spearheaded a €75m Series A financing in Norwegian biotech Calluna Pharma. The clinical-stage company resulted from the merger of Oxitope Pharma and Arxx Therapeutics.

Ruben de Francisco, Founder & CEO Onera Health. © Onera Health NV

Sleep diagnostics specialist Onera Health NV has closed a €30m (US$32m) Series C financing round co-led by EQT Life Sciences and Gimv.

© Enifer

Microbial production specialist Enifer has secured a €12m grant from Business Finland to build a mycoprotein ingredient factory with a capacity of 300,000 tonnes annually.

Mogu Panels are made from soft, foam-like mycelium materials and of upcycled textile residues. © Mogu Srl

Italian mycelium specialist Mogu Srl has closed a €11m Series A financing co-led by CDP Venture Capital and the  European Circular Bioeconomy Fund (ECBF VC)

Antibiotic resistance tests; the bacteria in the culture on the left are sensitive to the antibiotics contained in the white paper discs. The bacteria on the right are resistant to most of the antibiotics. © Dr Graham Beards  wikipedia.org

Novo Nordisk Foundation has partnered with CARB-X investing US$25m to help SMEs to fight drug-resistant infections.

Brown and white fat cells. © Patrick Seale, University of Pennsylvania School of Medicine/NIH

Italian Resalis Therapeutics Srl has baged €10m in a Series A financing led by Sunstone Life Science Ventures to complete a Phase I study for RES-010 in obesity.